Literature DB >> 1593976

Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status.

C D Coles1, K A Platzman, I Smith, M E James, A Falek.   

Abstract

Effects on fetal growth and neonatal behavior of cocaine and alcohol use in pregnancy were investigated in infants born to women in a low-income, predominantly black population. Despite the increased use of cocaine by pregnant women and the accompanying public concern, behavioral studies of exposed neonates are limited in number and scope. In most studies, confounding factors (e.g., polydrug abuse, prematurity, infant health status) have not been controlled so the actual effects of cocaine and other drug exposure are not clear. Accordingly, this study investigated effects of prenatal drug exposure although controlling experimentally for other factors known to be associated with poor outcomes in infants: prematurity, other illicit drug use, associated diseases (e.g., sexually transmitted diseases [STDs]), and duration of drug use. In addition, other factors statistically controlled were: experimenter effects, timing of assessment, and effects of duration, amount, and frequency of cocaine, alcohol, marijuana, and nicotine exposure. One hundred and seven full-term infants were assessed at 2, 14, and 28 days using the Brazelton Neonatal Behavioral Assessment Scale (BNBAS) by testers blind to infant status. Growth factors (i.e., birthweight, length, head circumference) were also assessed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593976     DOI: 10.1016/0892-0362(92)90025-6

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  40 in total

1.  Increased "default mode" activity in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

2.  Memory and brain volume in adults prenatally exposed to alcohol.

Authors:  Claire D Coles; Felicia C Goldstein; Mary Ellen Lynch; Xiangchuan Chen; Julie A Kable; Katrina C Johnson; Xiaoping Hu
Journal:  Brain Cogn       Date:  2010-11-09       Impact factor: 2.310

3.  Arousal modulation in cocaine-exposed infants.

Authors:  M Bendersky; M Lewis
Journal:  Dev Psychol       Date:  1998-05

4.  Medical and Psychologic Risks of Maternal Cocaine Use.

Authors:  Lynn Singer; Robert E Arendt; Sonia Minnes; Rachel M Garber
Journal:  Resid Staff Physician       Date:  1997-10

5.  Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.

Authors:  Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-09-26       Impact factor: 3.763

6.  Longitudinal changes of amygdala and default mode activation in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Claire D Coles; Mary Ellen Lynch; Yuejia Luo; Xiaoping Hu
Journal:  Neurotoxicol Teratol       Date:  2015-11-11       Impact factor: 3.763

7.  Effects of prenatal cocaine exposure on infant reactivity and regulation.

Authors:  Rina D Eiden; Shannon McAuliffe; Lorig Kachadourian; Claire Coles; Craig Colder; Pamela Schuetze
Journal:  Neurotoxicol Teratol       Date:  2008-09-10       Impact factor: 3.763

8.  Recursive cluster elimination based support vector machine for disease state prediction using resting state functional and effective brain connectivity.

Authors:  Gopikrishna Deshpande; Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Xiaoping Hu
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

9.  Prenatal drug exposure: neurodevelopmental outcome and parenting environment.

Authors:  M Black; M Schuler; P Nair
Journal:  J Pediatr Psychol       Date:  1993-10

10.  Prenatal cocaine exposure alters emotional arousal regulation and its effects on working memory.

Authors:  Zhihao Li; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Stephen LaConte; Xiaoping Hu
Journal:  Neurotoxicol Teratol       Date:  2009-08-21       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.